Effect of verapamil on daunorubicin accumulation in human leukemic cells with different levels of MDR1 gene expression - PubMed (original) (raw)
Effect of verapamil on daunorubicin accumulation in human leukemic cells with different levels of MDR1 gene expression
A Gruber et al. Leuk Res. 1993 Apr.
Abstract
The purpose of the present study was to evaluate the distribution of the multiple drug resistance phenotype in leukemic cells with different levels of mdr1 gene expression. Peripheral leukemic cells from 8 patients (5 with detectable and 3 with undetectable mdr1 RNA levels) were incubated with daunorubicin (1 microM) in the absence and presence of verapamil (6.6 microM). Daunorubicin accumulation in individual cells was analysed by flow cytometry. Verapamil increased (16-45%) the mean daunorubicin accumulation in 7 of the 8 cell samples. In cells from 4 of these 7 patients, the fluorescence histograms showed a general increase of daunorubicin accumulation. The increase was limited to a small subpopulation of cells in one patient. In the remaining two patients an increase of daunorubicin accumulation was seen in the majority of cells, while cells with the highest accumulation were unaffected. In conclusion, verapamil can increase daunorubicin accumulation in leukemic cells with and without detectable mdr1 gene expression and the increase seems to affect the majority of the cell population.
Similar articles
- Overexpression of the mdr1 gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A.
Nooter K, Sonneveld P, Oostrum R, Herweijer H, Hagenbeek T, Valerio D. Nooter K, et al. Int J Cancer. 1990 Feb 15;45(2):263-8. doi: 10.1002/ijc.2910450210. Int J Cancer. 1990. PMID: 1968051 - Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.
Herweijer H, Sonneveld P, Baas F, Nooter K. Herweijer H, et al. J Natl Cancer Inst. 1990 Jul 4;82(13):1133-40. doi: 10.1093/jnci/82.13.1133. J Natl Cancer Inst. 1990. PMID: 1972761 - Flow cytometric study of idarubicin and daunorubicin accumulation and the effect of verapamil in leukemic cell lines and fresh cells from patients with acute non-lymphoblastic leukemia.
Boiron JM, Belloc F, Montastruc M, Cony-Makhoul P, Dumain P, Marit G, Mahon FX, Puntous M, Lopez F, Lacombe F, et al. Boiron JM, et al. Leuk Res. 1994 May;18(5):313-8. doi: 10.1016/0145-2126(94)90014-0. Leuk Res. 1994. PMID: 8182921 - Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
Muller C, Goubin F, Ferrandis E, Cornil-Scharwtz I, Bailly JD, Bordier C, Bénard J, Sikic BI, Laurent G. Muller C, et al. Mol Pharmacol. 1995 Jan;47(1):51-6. Mol Pharmacol. 1995. PMID: 7838133 - Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression.
Marie JP, Faussat-Suberville AM, Zhou D, Zittoun R. Marie JP, et al. Leukemia. 1993 Jun;7(6):825-31. Leukemia. 1993. PMID: 8099135
Cited by
- Intracellular pH and the control of multidrug resistance.
Simon S, Roy D, Schindler M. Simon S, et al. Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1128-32. doi: 10.1073/pnas.91.3.1128. Proc Natl Acad Sci U S A. 1994. PMID: 8302842 Free PMC article. - Mapping genes that contribute to daunorubicin-induced cytotoxicity.
Duan S, Bleibel WK, Huang RS, Shukla SJ, Wu X, Badner JA, Dolan ME. Duan S, et al. Cancer Res. 2007 Jun 1;67(11):5425-33. doi: 10.1158/0008-5472.CAN-06-4431. Cancer Res. 2007. PMID: 17545624 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical